It can treat metabolic dysfunction-associated fatty liver disease (MAFLD) by decreasing caspase-3 and p53 and increasing B-cell lymphoma 2 (Bcl-2) levels, which helps to reduce liver fat accumulation [111]. Here, BCL2 is linked to fatty liver disease.